INNOVATIVE EYEWEAR, INC. Unrealized Gain (Loss) on Investments
INNOVATIVE EYEWEAR, INC. (LUCY) reported Unrealized Gain (Loss) on Investments of $25.68 thousand for the 1-month period ending 2025-10-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-08-14
- INNOVATIVE EYEWEAR, INC. unrealized gain (loss) on investments for the quarter ending 2025-06-30 was $0.00.
- INNOVATIVE EYEWEAR, INC. unrealized gain (loss) on investments for the quarter ending 2025-03-31 was $104.82K.
- INNOVATIVE EYEWEAR, INC. unrealized gain (loss) on investments for the quarter ending 2024-12-31 was $56.45K.
- INNOVATIVE EYEWEAR, INC. unrealized gain (loss) on investments for the quarter ending 2023-09-30 was $26.16K.
- INNOVATIVE EYEWEAR, INC. unrealized gain (loss) on investments for fiscal 2024 was $62.57K.
| Period end | Unrealized Gain (Loss) on Investments 1 month | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 3 month as first filed | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|---|---|
| 2025-10-31 | $25.68K 10-K · filed 2026-03-25 | |||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $104.82K 10-Q · filed 2026-08-14 | $161.27K derived: sum of 3 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $104.82K 10-K · filed 2026-03-25 | $104.82K 10-Q · filed 2026-05-14 | $62.57K 10-Q · filed 2025-05-13 | $161.27K derived: sum of 2 quarters · filed 2026-05-14 | ||
| 2024-12-31 | $56.45K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $62.57K 10-K · filed 2025-03-24 | ||||
| 2024-09-30 | $6.12K 10-Q · filed 2024-11-12 | |||||
| 2023-09-30 | $26.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $27.18K 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | $1.02K 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |